Caroline Levy analyst

Currently out of the existing stock ratings of Caroline Levy, 30 are a BUY (50.85%), 22 are a HOLD (37.29%), 7 are a SELL (11.86%).

Caroline Levy

Work Performance Price Targets & Ratings Chart

Analyst Caroline Levy, carries an average stock price target met ratio of 73.23% that have a potential upside of 24.45% achieved within 604 days. Previously, Caroline Levy worked at MACQUARIE, CLSA.

Caroline Levy’s has documented 108 price targets and ratings displayed on 12 stocks. The coverage was on Consumer Defensive, Basic Materials sectors.

Most recent stock forecast was given on BUD, Anheuser Busch Inbev NV ADR at 28-Oct-2019.

Wall Street Analyst Caroline Levy

Analyst best performing recommendations are on SAM (BOSTON BEER COMPANY).
The best stock recommendation documented was for SAM (BOSTON BEER COMPANY) at 4/26/2018. The price target of $225 was fulfilled within 1 day with a profit of $8.45 (3.9%) receiving and performance score of 39.02.

Average potential price target upside

BUD Anheuser Busch Inbev NV ADR CL Colgate-Palmolive Company EL Estee Lauder Companies PEP PepsiCo PG Procter & Gamble Company SAM Boston Beer Company STZ Constellation Brands DEO Diageo PLC ADR KMB Kimberly-Clark MNST Monster Beverage Corp CHD Church & Dwight Company CC Chemours Co

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Feb-2026

$97

$23.57 (32.10%)

$93

2 months 4 days ago
(31-Jul-2026)

1/4 (25%)

$10.52 (12.16%)

137

Buy Since 07-May-2021

2 months 8 days ago
(27-Jul-2026)

14/17 (82.35%)

$17.06 (31.39%)

777

Buy Since 08-Sep-2023

$84.5

$11.07 (15.08%)

$78

3 months 3 days ago
(02-Jul-2026)

9/9 (100%)

$3.17 (3.90%)

435

Hold Since 27-Feb-2025

$89

$15.57 (21.20%)

3 months 9 days ago
(26-Jun-2026)

1/2 (50%)

$3.91 (4.60%)

48

Buy Since 29-Nov-2023

$93.83

$20.4 (27.78%)

$79

4 months 28 days ago
(07-May-2026)

12/13 (92.31%)

$14.75 (18.65%)

315

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?